Sign In
Buy DTIL
$6.04
-0.280 (-4.43%)
At Close: Jun 03, 2026
Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS), an oncology-focused biopharmaceutical company working to create best-in
Bob Goeltz to Join Arcus Biosciences as Chief Financial Officer | | IT Business Net
09:05pm, Tuesday, 07'th Jul 2020
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that Bob Goeltz w
Bob Goeltz to Join Arcus Biosciences as Chief Financial Officer
12:00am, Tuesday, 07'th Jul 2020
Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced t
Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
11:00am, Monday, 06'th Jul 2020
Precision BioSciences, Inc. (DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, today announced that the Company
Hedge Funds Are Nibbling On Precision BioSciences, Inc. (DTIL)
08:33pm, Sunday, 05'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
7-Eleven Is Piloting Voice Commands For Payments at the Pump
12:54pm, Thursday, 02'nd Jul 2020
Global retail chain 7-Eleven recently announced it is piloting its Fuel Loyalty program, which is designed to provide contactless payment options to reduce touc
A Guide to Investing in Gene Editing Stocks
05:59am, Tuesday, 16'th Jun 2020
If we had to pick one disruptive technology that has the most potential to change mankind, it would be synthetic biology (synbio). A critical component of synbio is gene editing. You cannot have one w
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Global Blood Therapeutics (GBT –
Aptorum Group Limited Strengthens Its Presence in the US With the Appointment of Dr. Kira Sheinerman
12:00am, Monday, 15'th Jun 2020
Aptorum Group Limited (NASDAQ:APM), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs
3 “Strong Buy” Penny Stocks With Massive Upside Ahead
01:57pm, Friday, 12'th Jun 2020
Penny stocks, you either love them or you hate them. One of the obvious draws of these stocks trading for under $5 per share is the ability to get more
'It legitimises doing nothing': Cloud spotting gains new fans amid coronavirus chaos
09:18pm, Thursday, 11'th Jun 2020
Cloud spotting is enjoying a renaissance as aficionados laud clouds as "a moment or meteorological mediation" that can provide reassurance in troubled times.
CRISPR Market Analysis By Industry Growth, Size, Share, Demand, Trends and Research Report
11:19am, Thursday, 11'th Jun 2020
Jun 11, 2020 (AmericaNewsHour) --
Global CRISPR Market Size Study by Application(Genome Editing, Genetic Engineering, Gene Library, CRISPR Plasmid, Human...
William Blair Reiterates Buy Rating for Precision BioSciences (NASDAQ:DTIL)
04:28am, Wednesday, 10'th Jun 2020
Precision BioSciences (NASDAQ:DTIL)‘s stock had its “buy” rating reaffirmed by William Blair in a note issued to investors on Monday, AnalystRatings.com reports. DTIL has been the topic of sever
